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ABSTRACT. The aim of this prospective, randomized clinical trial was to compare the total number of anesthetic interventions (TNAI) 
performed by the anesthetist to treat cardiovascular depression or arousal/movement episodes in dogs receiving intrathecal and general 
anesthesia (GA), maintained using propofol-based TIVA (group P) or isoflurane (group I). Mean arterial pressure (MAP) before (T0) and 
12 min after intrathecal anesthesia (T1) and intraoperative vasoactive consumption were also compared. The TNAI to deepen the anesthetic 
plane or to treat hemodynamic depression in the pre-surgical and intra-surgical period was calculated in forty-two client-owned dogs 
randomly assigned to group P or I. Ten dogs for each group complied with the inclusion criteria and were analyzed. In pre-surgical period, 
the TNAI was higher in Group I [2 (0–5)] than Group P [0 (0–2)] (P=0.022), and ephedrine consumption was also higher in Group I [75 
(0–200) µg/kg)] than Group P [(0 (0–50)] (P=0.016). MAP (mmHg) in Group P was 79 (66–95) at T0 and 65 (59–86) at T1 and 67.5 (50–73) 
and 57 (53–66) in Group I, respectively. At T0 and T1, MAP was higher in Group P (P=0.005 and P=0.006, respectively). No differences 
were found between the two groups in the intrasurgical period (P>0.05). This study shows that the GA protocol can have a relevant impact 
on the TNAI performed by the anesthetist in the pre-surgical period of anesthesia, to treat cardiovascular depression or arousal/movement 
episodes in dogs receving intrathecal anesthesia.
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The operating theater is a place where balancing produc-
tivity with patient safety and staff satisfaction is extremely 
difficult. The anesthetist must be able to find the best com-
promise between safety and smooth patient turnover, while 
guaranteeing excellent perioperative conditions for both the 
patient and the surgeon. When working in a busy veterinary 
hospital, anesthetists may take responsibility for more than 
one case at the same time; therefore, simple and efficacious 
anesthetic protocols that require less effort by the anesthetist 
are preferable.
For orthopedic patients, combining general and regional 
anesthesia techniques (combined anesthesia) can provide ex-
cellent perioperative conditions with a high degree of safety 
[3, 13, 21]. When combined anesthesia is employed, a pro-
tocol is required to guarantee optimum hemodynamic con-
ditions, a stable anesthetic plane and immobility. Although 
there is a lack of evidence in the literature, presumably, some 
perioperative complications that affect subjects undergoing a 
regional block could be influenced by the anesthetic protocol 
used. The most frequent complication requiring anesthetist 
attention during the perioperative period in healthy dogs un-
dergoing neuraxial anesthesia is cardiovascular depression 
[22], However, Bosmans et al. [1] also reported a remark-
ably high incidence of arousal/movement (A/M) episodes 
(4/23) when performing neuraxial anesthesia in isoflurane-
anesthetized dogs. Even though the veterinary literature 
does not provide more information on this complication, 
the authors’ clinical impression is that when anesthesia is 
maintained with a volatile agent in non or lightly premedi-
cated dogs, the A/M incidence is close to or superior to that 
found by Bosmans et al. [1] in dogs undergoing a regional 
block. Both hypotension and A/M events in dogs receiving 
regional anesthesia can increase the anesthetist’s workload, 
the procedural time, and the administration of vasoactive 
drugs or a bolus of propofol, thus making these techniques 
less attractive in clinical practice. Hypotension can increase 
the perioperative risk of morbidity and mortality [9, 26]. In 
contrast to humans, propofol-based total intravenous anes-
thesia (TIVA) seems to decrease the risk of hypotension in 
dogs. Iizuka et al. [11] reported the incidence of intraopera-
tive hypotension (IOH) in dogs anesthetized with isoflurane-
fentanyl or propofol-fentanyl as being 65.3% and 27.6%, 
respectively, suggesting that propofol-fentanyl is associated 
with a lower risk of IOH than isoflurane-fentanyl anesthesia. 
Moreover, the authors’ clinical impression suggests that pro-
pofol-based TIVA decreases the incidence of A/M compared 
with isoflurane-induced anesthesia in lightly premedicated 
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dogs, while a regional block is being performed.
The aim of this study was to compare the total number of 
anesthetic interventions (TNAI) performed by the anesthe-
tist to treat cardiovascular depression or A/M episodes and 
to monitor arterial blood pressure (ABP), heart rate (HR) 
and the amount of ephedrine administered in dogs that had 
received an intrathecal injection of bupivacaine and mor-
phine hyperbaric solution and who were being maintained in 
general anesthesia (GA) with isoflurane or propofol.
MATERIALS AND METHODS
This study was approved by the Ethical Committee of the 
University of Padua (Prot. N. 242819), and all owners gave 
their informed consent. All anesthetic procedures were per-
formed by the same experienced operator, who was aware of 
the assigned technique.
Animals: Inclusion criteria: Dogs older than 6 months pre-
senting to the Clinic, from January 2014 to January 2015, for 
various scheduled surgical procedures involving the pelvic 
limbs, based on the American Society of Anesthesiologists 
(ASA) physical status classification I or II as determined fol-
lowing clinical examination.
Anesthesia protocols: Before induction of GA, catheter-
ization of the cephalic vein was performed. General anes-
thesia was then induced by administering fentanyl 2.5 µg/kg 
intravenously (IV) and propofol to effect. After orotracheal 
intubation and inflation of the cuff, the dog was connected 
to the breathing system. All patients included in this study 
received intermittent positive pressure ventilation (Cato, 
Draeger, Germany), and their metatarsal artery was catheter-
ized. The electrocardiogram, HR, invasive blood pressure, 
respiratory rate, arterial oxygen saturation, fraction of in-
spired oxygen (FiO2), end-tidal carbon dioxide concentra-
tion (FE’CO2), end-tidal isoflurane concentration (FE’Iso) 
and esophageal temperature were monitored continuously 
(GE Datex Ohmeda AS). Lactated Ringer’s solution (Ringer 
Lattato; Fresenius Kabi, Isola della Scala (VR), Italy) was 
administered IV during anesthesia in all of the dogs. Once 
the plane of anesthesia was stable, the systolic pressure 
variation (SPV) was measured with the dog in left lateral 
recumbency in accordance with Gouvêa & Gouvêa [8]. In 
brief, the ‘wedge pressure’ function in the monitor’s invasive 
pressures channel was applied to the systemic arterial curve: 
(Step 1) the arterial pressure curve was labeled ‘pulmonary 
arterial pressure’, and the scale was adjusted accordingly; 
(Step 2) the ‘wedge pressure menu’ was accessed; (Step 3) 
the ComWheel was pressed to confirm; the screen freezes at 
this point, and a blue horizontal line appears; and (Step 4) 
the operator is free to move this line to the uppermost point 
of the curve and then move it down to the lowest systolic 
pressure [8].
The SPV was calculated as the difference between the 
maximum and the minimum systolic pressure (SPmax and 
SPmin, respectively) over a single respiratory cycle and 
was expressed as a percentage: SPV-%=100 × (SPmax −
SPmin)/(SPmax + SPmin)/2. The median value over three 
consecutive SPV measurements was taken. If the dog was 
not completely suited to mechanical ventilation, or there 
was a detectable HR variability, or the mean arterial pressure 
(MAP) was <50 mmHg, SPV measurement was suspended. 
Propofol (1 mg/kg) was given and SPV measurement was 
resumed 5 min later, if abnormalities in the ventilatory pat-
tern were due to an inadequate depth of anesthesia. Dogs 
with an MAP <50 mmHg, compatible with a deep plane of 
anesthesia, had their FE’ISO decreased. Subjects were ex-
cluded from the study, if these abnormalities did not respond 
to the relevant interventions or if they required a vasopres-
sor. Every dog with an SPV higher than 4.5% under a peak 
inspiratory pressure of 8 cmH2O received 3 ml/kg of lactated 
Ringer’s solution intravenously at a rate of 999 ml/hr using 
an infusion pump [21]. Every dog with an SPV higher than 
4.5% not responder to fluid administration were excluded. 
The body temperature was maintained above 35°C during 
the perioperative period using an active heating system 
(Bair Hugger Warmer Model 505, Augustine Biomedical 
Design, Eden Prairie, MN, U.S.A.). General anesthesia was 
maintained in dogs assigned to Group I with isoflurane and 
to Group P with a propofol-based TIVA. Median values of 
HR and ABP were recorded before (T0) and 12 min after in-
trathecal injection (T1). When hypotension and bradycardia 
were observed, according to the definition given below, the 
lowest value registered by the monitor was recorded in the 
results.
In order to perform the regional technique, anesthetized 
dogs were positioned in lateral recumbency, and the skin over 
the L3-S1 vertebrae was aseptically prepared after clipping 
the hair. A lack of cerebral spinal fluid (CSF) outflow was 
considered a procedural failure in intrathecal anesthesia. The 
intrathecal injection was administered using a paramedian 
approach at the level of the intervertebral space between L5 
and L6 using a 75-mm-long 25 G Quincke needle (Spinal 
needle; Pic, Grandate (CO), Italy). Once the CSF outflow 
became visible in the hub of the needle, the intrathecal solu-
tion was injected over 20 sec. The needle bevel always faced 
cranially during administration of the intrathecal solution. 
Once the injection was complete, dogs were maintained 
in lateral recumbency, with the pelvic limb to be operated 
on lowermost, for 12 min and were then placed in dorsal 
recumbency.
The bupivacaine (Bupisen iperbarica 0.5%; Galenica Sen-
ese, Monteroni d’Arbia (SI), Italy) dose calculations were 
based on body mass (BM) and spinal cord length (SCL) as 
suggested by Sarotti et al. [22].
Bupivacaine 0.5% (mg): 0.3 BM (kg) + 0.05 SCL (cm)
Spinal cord length (SCL) was recorded as the distance 
between the caudal part of the spinal process of L7 and the 
occipital bone.
The 1% morphine dose was 0.3 mg in dogs less than 10 
kg, 0.5 mg in dogs between 11 and 20 kg, and 1 mg in dogs 
over 20 kg (Sarotti et al.) [23].
Event definition and treatment: Hypotension was defined 
as being when every MAP value was lower than 60 mmHg. 
When hypotension was noticed, the anesthesia plane was 
lightened and SPV was checked again. Every dog with an 
SPV higher than 4.5% under a peak inspiratory pressure of 8 
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cmH2O received 3 ml/kg of lactated Ringer’s solution intra-
venously at a rate of 999 ml/hr using an infusion pump [21]. 
When these actions were not able to raise the MAP above 60 
mmHg, a bolus of ephedrine was administered until a maxi-
mal total dose of 200 µg/kg was reached. If the hypotension 
did not respond to these treatments, a noradrenaline infusion 
at 0.1–1 µg/kg/min was administered.
Bradycardia was defined as being when every HR value 
was below 60 bpm. When bradycardia was observed, atro-
pine at 20 µg/kg IV was administered. Bradycardia ranging 
between 55 and 59 bpm as a consequence of ephedrine ad-
ministration was not treated.
An A/M episode was defined as any body movement or 
sign of lightening of the GA, such as spontaneous or rapid 
eye blinking, resistance towards the ventilator or muscular 
tremors. When lightening of anesthesia was observed, 1 mg/
kg IV propofol was administered.
The TNAI was defined as being the total number of mea-
sures taken by the anesthetist either to deepen the anesthetic 
plane or to treat hemodynamic depression between stabiliza-
tion of the anesthetic plane after induction of anesthesia and 
skin incision.
Statistical analysis: Dogs were assigned to one of the 
two treatment groups according to a computer-generated 
randomization sequence after the placement of a catheter 
in the metatarsal artery. The estimated sample size required 
to detect a difference in the primary endpoint (difference in 
MAP between groups) with a power of 80% and an alpha 
error of 5% using a two independent groups study design has 
been calculated. The effect size (d) of 1.42 was obtained as-
suming a MAP difference at T1 of 10 mmHg, with a standard 
deviation of 7 mmHg. The minimum sample size calculated 
was nine subjects for each group. Categorical variables were 
reported as frequencies and percentages, and differences 
between groups were analyzed using the Fisher’s exact test. 
Continuous variables were checked for normal distribution 
by visual inspection of bar graphs and histograms, and by 
using the Shapiro–Wilk test. Data not normally distributed 
were reported as the median and the range (minimum–maxi-
mum), and differences were analyzed using the Mann-
Whitney U test. The significance level was set at 5% for all 
statistical methods (MedCalc Software for Windows version 
12.5, Ostend, Belgium).
RESULTS
Forty-two dogs were enrolled in this study. Intrathecal 
injection in 5/42 (12%) and the placement of a catheter 
into the dorsal metatarsal artery in 15/42 (36%) dogs failed, 
and two cases were excluded because their SPV was higher 
than 4.5% despite the administration of a bolus of fluid. The 
remaining 20 dogs, which had complied with the inclusion 
criteria, were divided evenly into two groups and analyzed. 
Two dogs in Group I and one in Group P received a bolus of 
fluid before the intrathecal injection, because their SPV was 
higher than 4.5% under a peak inspiratory pressure constant-
ly maintained at 8 cmH2O. The demographic data (Breed, 
Age, BM, SCL and ASA category) of both groups can be 
found in Appendix Table A1. Procedural data concerning the 
median local anesthetic dose used for neuraxial blockade, 
the median dose of morphine, the median dose of propofol 
used for induction of anesthesia, the median dose of propofol 
per kilogram of body weight per hour and the median value 
of FE’iso in the first hour are reported in Table 1. The MAP 
at T0 and at T1 was higher in Group P, as is shown in Fig. 
1 (P=0.0005 and P=0.006). Complete hemodynamic data 
at T0 and T1 are reported in Table 2. Hypotension, vasoac-
tive consumption, A/M, propofol consumption due to A/M, 
bradycardia, atropine consumption and TNAI in Groups P 
and I in pre-surgery and intra-surgical periods are reported, 
respectively, in Tables 3 and 4. In pre-surgery period, TNAI 
was higher in Group I, as shown in Fig. 2 (P=0.022), while 
in intraoperative period, TNAI was not different between 
groups (P>0.05). In pre-surgery period, ephedrine consump-
tion was higher in Group I (P=0.016), while in intraoperative 
period, ephedrine consumption was not different between 
groups (P>0.05).
DISCUSSION
This study shows that the GA protocol can have a relevant 
impact on the total number of interventions performed by the 
anesthetist in the pre-surgical period of anesthesia, to treat 
cardiovascular depression or arousal/movement episodes in 
dogs receiving intrathecal anesthesia.
This aspect of combined anesthesia has not been investi-
gated in the veterinary literature, even though such anesthe-
sia is very frequently used in veterinary practice. According 
to this study, dogs, undergoing neuraxial anesthesia, which 
was maintained under anesthesia using a propofol-based 
TIVA, required less interventions to control cardiovascular 
depression or involuntary movements compared with dogs 
maintained under isoflurane-induced anesthesia. This can 
be an important feature when deciding on an anesthetic 
protocol in a busy veterinary practice, where maintaining an 
elevated surgical patient flow is important. There is no pub-
lished work examining the relationship between workload 
and anesthetic safety in veterinary care. In a survey of the 
medical sector [6], 63% of the respondents suggested that 
they had made workload-related errors. Regional anesthesia 
techniques can only contribute significantly to the quality 
and efficiency of the perioperative care of veterinary patients 
when complications, possibly arising from these procedures, 
are minimized. In fact, in the authors’ experience, when per-
forming a regional anesthesia technique using a volatile an-
esthetic, it is more difficult to resolve the conflicting require-
ments of having an adequate and stable hypnotic level while 
limiting hypotension and cardiovascular depression in dogs. 
In particular, subjects undergoing neuraxial anesthesia are 
exposed to a high risk of hypotension [6], which is mainly 
due to sympathetic nerve supply blockade and bradycardia. 
The degree to which this occurs depends on the balance be-
tween sympathetic and parasympathetic activities, the extent 
of the sympathetic block, the degree of cardiac filling and the 
adequacy of cardiac function [28]. Additionally, the concur-
rent administration of systemic anesthetic drugs, such as iso-
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flurane or propofol anesthetics, can impair the compensatory 
hemodynamic response (vasoconstriction in unblocked areas 
of the body) to neuraxial administration of local anesthetics 
[16, 25]. An experimental study in vagotomized cats found 
that the baroreceptor reflex is significantly better maintained 
with propofol than with isoflurane at equipotent doses [24]. 
Isoflurane and propofol administration causes hypotension 
mainly through a combination of three mechanisms: myo-
cardial contractility impairment, a decrease in systemic 
vascular resistance and an increase in venous capacitance 
[14, 18, 24, 29]. However, a lower risk of hypotension has 
been found when propofol was compared with isoflurane to 
maintain anesthesia in dogs undergoing various surgical and 
diagnostic procedures [13]. A similar finding has been re-
ported in cats when general anesthesia was maintained with 
propofol [14], but it differs from humans in that propofol 
Table 3. Pre-surgical period: hypotension, vasoactive consumption, arousal/movement (A/M), propofol consumption due to 
A/M, bradycardia, atropine consumption and the total number of anesthetic interventions (TNAI) in Groups P and I
Group P (n=10) Group I (n=10) P-value
Hypotension (%) 3/10 (30%) 6/10 (60%) 0.37
Total ephedrine consumption (µg/kg) [median (range)] 0 (0–50) 75 (0–200) 0.016
Total noradrenalin consumption (µg/kg) [median (range)] 0 0 >0.05
A/M (%) 1/10 (10%) 5/10 (50%) 0.07
Total propofol consumption due to A/M (mg/kg) [median (range)] 0 (0–1) 1.5 (0–3) 0.019
Bradycardia (%) 0/10 (0%) 2/10 (20%) 0.47
Total Atropine consumption (µg/kg) [median (range)] 0 0 (0–20) >0.05
TNAI (n) [median (range)] 0 (0–2) 2 (0–5) 0.022
Table 4. Intra-surgical period: hypotension, vasoactive consumption, arousal/movement (A/M), propofol consumption due 
to A/M, bradycardia, atropine consunption and the total number of anesthetic interventions (TNAI) in Groups P and I
Group P (n= 10) Group I (n=10) P-value
Hypotension (%) 1/10 (10%) 0/10 (0%) >0.05
Total ephedrine consumption (µg/kg) [median (range)] 0 (0–25) 0 >0.05
Total noradrenaline comsumption (µg/kg) [median (range)] 0 0 >0.05
A/M (%) 0 1/10 (10%) >0.05
Total propofol consumption due to A/M (mg/kg) [median (range)] 0 0 (0–1) >0.05
Bradycardia (%) 0/10 (0%) 1/10 (10%) >0.05
Total Atropine comsumption (µg/kg) [median (range)] 0 0 (0–20) >0.05
TNAI (n)[median (range)] 0 (0–1) 0 (0–1) >0.05
Table 1. Procedural data [median (range)] for Groups I and P
Group P (n=10) Group I (n=10) P-value
Bupivacaine dose (mg) 8.7 (4–14.9) 13.5 (2.31–16) 0.21
Bupivacaine dose related to BM (mg/kg) 0.42 (0.40–0.59) 0.45 (0.4–0.85) 0.32
Bupivacaine dose related to SCL (mg/cm) 0.15 (0.1–0.19) 0.18 (0.07–0.18) 0.32
Morphine dose (mg) 1 (0.3–1) 1 (0.3–1) 0.81
Morphine dose related to  BM (mg/kg) 0.03 (0.027–0.07) 0.03 (0.025–0.11) 0.28
Propofol induction bolus (mg/kg) 5 (4–6) 5 (4–7) 0.56
Mean propofol rate infusion in the first hours (mg/kg/h) versus  
mean ET isoflurane (%) in the first hour
25 (20–35) 1 (0.8–1.2) Not evaluated
BM: body mass; SCL: spinal cord length; ET: end-tidal.
Table 2. Hemodynamic data [median (range)] for Groups I and P 
before intrathecal injection (T0) and 12 min later (T1)
Group P (n=10) Group I (n=10) P-value
SAP T0 (mmHg) 115 (94–143) 94 (75–134) 0.0005
MAP T0 (mmHg) 79 (66–95) 67.5 (50–73) 0.0005
DAP T0 (mmHg) 63.5 (59–76) 55 (33–60) 0.0007
HR T0 (bt/min) 87 (76–150) 92 (74–135) 0.56
SAP T1 (mmHg) 102.5 (86–129) 87 (74–104) 0.041
MAP T1 (mmHg) 65 (59–86) 57 (53–66) 0.006
DAP T1 (mmHg) 51.5 (45–69) 47 (41–53) 0.034
HR T1 (bt/min) 76.5 (60–100) 75 (54–130) 0.61
HR: heart rate; SAP: systolic arterial pressure; MAP: mean arterial pres-
sure; DAP: diastolic arterial pressure.
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does not seem to provide clear advantages over inhalation 
anesthetics in terms of reducing IOH [5, 15]. In our study, 
the incidence of hypotension in the group I was double than 
in the group P, however, the sample size of the study was not 
adequate to reach a statistically significant difference on this 
aspect. Nevertheless, the amount of ephedrine consumed in 
the group I was significantly higher than in the group P in 
the pre-surgery period (P=0.016). Compared with isoflurane, 
propofol better preserves aortic pressure and increases aor-
tic compliance and thus improves the energy transmission 
from the left ventricle to the arterial system [4]. Goodchild 
& Serrao [7], in an experimental study, proved that cardiac 
output and arterial pressure are well preserved at propofol 
blood concentrations commonly used during maintenance in 
dogs if the preload is maintained. These authors also found 
that the preload reduction by a veno-dilator effect is the main 
mechanism that causes a decrease in cardiac output when 
using propofol in this species.
Bradycardia plays an important role in neuraxial anesthe-
sia, causing hypotension. Cephalad spread of local anesthetic 
increases the likelihood of bradycardia via two postulated 
mechanisms: the blockade of sympathetic cardiac accelera-
tor fibers that arise at T1-T4 [10] and decreased venous re-
turn [17]. Even though in this study, a low incidence of bra-
dycardia was found, post-intrathecal injection lowering of 
blood pressure was not apparently compensated by a rise in 
HR. This may have been determined by the above-described 
mechanisms related to intrathecal anesthesia. In the current 
study, the decrease in HR due to intrathecal injection did not 
differ between the two groups. This finding is in agreement 
with the study of Deryck et al. [4], which concludes that HR 
did not differ between isoflurane and propofol anesthesia, 
whereas aortic pressure was higher in dogs anesthetized with 
propofol.
Group I subjects received a significantly higher amount 
of propofol to treat A/M episodes (P=0.019). Immobility is 
a fundamental requirement when a neuraxial block is car-
ried out, as movement can increase risks ranging from nerve 
block failure to causing spinal cord damage. Many subjects 
in Group I had a mean blood pressure close to 60 mmHg in 
the pre-block period, and the dogs may have been kept at a 
lighter anesthesia plane in an attempt to avoid hypotension, 
which thus favored A/M episodes. However, an increased 
risk of awareness has been reported in pediatric patients 
maintained under anesthesia with volatile anesthetic agents 
compared with using TIVA (awareness rate 5% Vs 0.2%) 
[12].
Dogs enrolled in the current study underwent volemic as-
sessment by measuring SPV after having reached a stable 
plane of anesthesia. SPV is a dynamic index of volemia 
validated in dogs undergoing graded exsanguination [19] 
and was recently characterized as a predictor of fluid respon-
siveness in the same species [20]. Fluids were administered 
when SPV (calculated as a percentage) was equal to or 
higher than 4.5% in an anesthetized dog under a peak inspi-
ratory pressure constantly maintained at 8 cmH2O. There is 
a high probability that the subject would have hemodynami-
cally benefited from a bolus of fluid. In the authors’ opinion, 
volemia assessment can be particularly important when 
comparing hemodynamic events after neuraxial anesthesia 
in order to avoid jeopardizing results, because hypovolemia 
is well known to worsen post-puncture hypotension in sub-
jects undergoing neuraxial anesthesia [2]. Even though, the 
importance of the volemic assessment in clinical practice, as 
well as during hemodynamic experimental studies, cannot 
Fig. 1. Box plots of the mean arterial pressure (MAP) 
before (T0) and 12 min after intrathecal injection (T1) 
in Groups P and I. MAP is higher in dogs in the Group 
P compared with those in Group I at T0 (P=0.0005) and 
T1 (P=0.006). Dots refer to the value of individual cases. 
The whiskers show the range values, the width of the box 
shows the interquartile range, and the bar in the box is the 
median value.
Fig. 2. Box plots of the total number of anesthetic 
interventions to deepen the anesthetic plane or to treat 
hemodynamic depression in the pre-surgical period is 
higher in Group I than in Group P (P=0.022). Dots 
refer to the value of individual cases. The whiskers 
show the range values, the width of the box shows 
the interquartile range, and the bar in the box is the 
median value.
D. SAROTTI, R. RABOZZI AND P. FRANCI1554
be underestimated, some limitations in this study on SPV 
use should be considered. Anesthesia was maintained with 
isoflurane, in the original study on the clinical use of SPV 
[21], and 4.5% has not been confirmed by any study as being 
the best threshold for fluid responsiveness when propofol is 
used to maintain anesthesia. This study compares isoflurane 
with propofol in the maintenance of anesthesia in the intra-
operative period. No data were collected on duration and 
quality of recovery. This can be considered a limitation, be-
cause recovery can be a period when complications can call 
for anesthetist involvement, and therefore, can contribute to 
the anesthetist’s workload. Tsai et al. [27], when comparing 
dogs’ recovery from anesthesia maintained with isoflurane 
or propofol, found that the isoflurane-maintained group 
stood more quickly than the propofol-maintained group 
(mean time 27.7 vs. 34.5 min), even though the incidence of 
adverse effects was not different.
In order to maximize the advantages in performing 
a regional anesthetic technique, the anesthesia protocol 
should be carefully planned. The use of different protocols 
can affect the number of complications arising during the 
anesthetic period when a regional anesthetic block is per-
formed. When intrathecal anesthesia is planned, maintaining 
anesthesia with propofol-based TIVA in dogs can guarantee 
better cardiovascular parameters, less A/M episodes and 
fewer interventions by the anesthetist than using volatile 
anesthetics in the pre-surgical period. These differences may 
be relevant to the safety of anesthetic procedures.
REFERENCES
 1. Bosmans, T., Schauvliege, S., Gasthuys, F., Duchateau, L., 
Marcilla, M. G., Gadeyne, C. and Polis, I. 2011. Cardiovascular 
effects of epidural administration of methadone, ropivacaine 
0.75% and their combination in isoflurane anaesthetized dogs. 
Vet. Anaesth. Analg. 38: 146–157. [Medline]  [CrossRef]
 2. Caplan, R. A., Ward, R. J., Posner, K. and Cheney, F. W. 1988. 
Unexpected cardiac arrest during spinal anesthesia: a closed 
claims analysis of predisposing factors. Anesthesiology 68: 
5–11. [Medline]  [CrossRef]
 3. Carpenter, R. L., Caplan, R. A., Brown, D. L., Stephenson, C. 
and Wu, R. 1992. Incidence and risk factors for side effects 
of spinal anesthesia. Anesthesiology 76: 906–916. [Medline] 
[CrossRef]
 4. Deryck, Y. L., Brimioulle, S., Maggiorini, M., de Canniere, D. 
and Naeije, R. 1996. Systemic vascular effects of isoflurane 
versus propofol anesthesia in dogs. Anesth. Analg. 83: 958–964. 
[Medline]  [CrossRef]
 5. Fanelli, G., Casati, A., Berti, M., Rossignoli L., Italian Study 
Group on Integrated Anaesthesia 1998. Incidence of hypotension 
and bradycardia during integrated epidural/general anaesthesia. 
An epidemiologic observational study on 1200 consecutive pa-
tients. Minerva Anestesiol. 64: 313–319. [Medline]
 6. Gaba, D. M., Howard, S. K. and Jump, B. 1994. Production pres-
sure in the work environment. California anesthesiologists’ at-
titudes and experiences. Anesthesiology 81: 488–500. [Medline] 
[CrossRef]
 7. Goodchild, C. S. and Serrao, J. M. 1989. Cardiovascular effects 
of propofol in the anaesthetized dog. Br. J. Anaesth. 63: 87–92. 
[Medline]  [CrossRef]
 8. Gouvêa, G. and Gouvêa, F. G. 2005. Measurement of systolic 
pressure variation on a Datex AS/3 monitor. Anesth. Analg. 100: 
1864. [Medline]  [CrossRef]
 9. Guyton, A. C. and Hall, J. E. 2006. Textbook of Medical Physi-
ology. 10th ed. WB Saunders, Philadelphia.
 10. Hwang, J., Min, S., Kim, C., Gil, N., Kim, E. and Huh, J. 2014. 
Prophylactic glycopyrrolate reduces hypotensive responses in 
elderly patients during spinal anesthesia: a randomized con-
trolled trial. Can. J. Anaesth. 61: 32–38. [Medline]  [CrossRef]
 11. Iizuka, T., Kamata, M., Yanagawa, M. and Nishimura, R. 2013. 
Incidence of intraoperative hypotension during isoflurane-
fentanyl and propofol-fentanyl anaesthesia in dogs. Vet. J. 198: 
289–291. [Medline]  [CrossRef]
 12. Jöhr, M. 2006. [Awareness: a problem in paediatric anaesthe-
sia?]. Anaesthesist 55: 1041–1049. [Medline]
 13. Kona-Boun, J. J., Cuvelliez, S. and Troncy, E. 2006. Evaluation 
of epidural administration of morphine or morphine and bupi-
vacaine for postoperative analgesia after premedication with 
an opioid analgesic and orthopedic surgery in dogs. J. Am. Vet. 
Med. Assoc. 229: 1103–1112. [Medline]  [CrossRef]
 14. Liehmann, L., Mosing, M. and Auer, U. 2006. A comparison 
of cardiorespiratory variables during isoflurane-fentanyl and 
propofol-fentanyl anaesthesia for surgery in injured cats. Vet. 
Anaesth. Analg. 33: 158–168. [Medline]  [CrossRef]
 15. Modesti, C., Sacco, T., Morelli, G., Bocci, M. G., Ciocchetti, P., 
Vitale, F., Perilli, V. and Sollazzi, L. 2006. Balanced anestesia 
versus total intravenous anestesia for kidney transplantation. 
Minerva Anestesiol. 72: 627–635. [Medline]
 16. Mutoh, T., Nishimura, R., Kim, H. Y., Matsunaga, S. and Sasaki, 
N. 1997. Cardiopulmonary effects of sevoflurane, compared 
with halothane, enflurane, and isoflurane, in dogs. Am. J. Vet. 
Res. 58: 885–890. [Medline]
 17. Otton, P. E. and Wilson, E. J. 1966. The cardiocirculatory effects 
of upper thoracic epidural analgesia. Can. Anaesth. Soc. J. 13: 
541–549. [Medline]  [CrossRef]
 18. Pagel, P. S. and Warltier, D. C. 1993. Negative inotropic effects 
of propofol as evaluated by the regional preload recruitable 
stroke work relationship in chronically instrumented dogs. An-
esthesiology 78: 100–108. [Medline]  [CrossRef]
 19. Perel, A., Pizov, R. and Cotev, S. 1987. Systolic blood pressure 
variation is a sensitive indicator of hypovolemia in ventilated 
dogs subjected to graded hemorrhage. Anesthesiology 67: 498–
502. [Medline]  [CrossRef]
 20. Rabozzi, R. and Franci, P. 2014. Use of systolic pressure varia-
tion to predict the cardiovascular response to mini-fluid chal-
lenge in anaesthetised dogs. Vet. J. 202: 367–371. [Medline] 
[CrossRef]
 21. Sarotti, D., Rabozzi, R. and Corletto, F. 2011. Efficacy and side 
effects of intraoperative analgesia with intrathecal bupivacaine 
and levobupivacaine: a retrospective study in 82 dogs. Vet. An-
aesth. Analg. 38: 240–251. [Medline]  [CrossRef]
 22. Sarotti, D., Rabozzi, R. and Franci, P. 2013. A retrospective 
study of efficacy and side effects of intrathecal administration 
of hyperbaric bupivacaine and morphine solution in 39 dogs 
undergoing hind limb orthopaedic surgery. Vet. Anaesth. Analg. 
40: 220–224. [Medline]  [CrossRef]
 23. Sarotti, D., Rabozzi, R. and Franci, P. 2015. Comparison of epi-
dural versus intrathecal anaesthesia in dogs undergoing pelvic 
limb orthopaedic surgery. Vet. Anaesth. Analg. 42: 405–413. 
[Medline]  [CrossRef]
 24. Sellgren, J., Biber, B., Henriksson, B. A., Martner, J. and Pontén, 
J. 1992. The effects of propofol, methohexitone and isoflurane 
on the baroreceptor reflex in the cat. Acta Anaesthesiol. Scand. 
ISOFLURANE VS PROPOFOL FOR SPINAL BLOCK 1555
36: 784–790. [Medline]  [CrossRef]
 25. Stanton-Hicks, M. A. 1975. Cardiovascular effects of extradural 
anaesthesia. Br. J. Anaesth. 47 suppl: 253–261. [Medline]
 26. Stoelting, R. K. and Hillier, S. C. 2006. Pharmacology and 
Physiology in Anesthetic Practice. 4th ed. Lippincott Williams 
& Wilkins, Philadelphia.
 27. Tsai, Y. C., Wang, L. Y. and Yeh, L. S. 2007. Clinical comparison 
of recovery from total intravenous anesthesia with propofol and 
inhalation anesthesia with isoflurane in dogs. J. Vet. Med. Sci. 
69: 1179–1182. [Medline]  [CrossRef]
 28. Veering, B. T. and Cousins, M. J. 2000. Cardiovascular and pul-
monary effects of epidural anaesthesia. Anaesth. Intensive Care 
28: 620–635. [Medline]
 29. Wouters, P. F., Van de Velde, M. A., Marcus, M. A., Deruyter, 
H. A. and Van Aken, H. 1995. Hemodynamic changes during 
induction of anesthesia with eltanolone and propofol in dogs. 
Anesth. Analg. 81: 125–131. [Medline]
Appendix
Table A1. Demographic data of dogs [median (range)] that met the inclusion criteria 
for Groups I and P
Group P (n=10) Group I (n=10) P-value
Breed (n) 7 Mongrels 5 Mongrels Not evaluated
1 Labrador 4 Labrador
1 Golden Retriever 1 Pointer
1 German Shepherd
Age (years) 5.5 (1.5–14) 7.5 (0.9–12.5) 0.8
BM (kg) 19.5 (7–35) 31.5 (2.7–40) 0.24
SCL (cm) 57.5 (44–75) 72.5 (30–80) 0.16
ASA Category (n) ASA I (8) ASA I (9) 1
ASA II (2) ASA II (1)
BM: body mass; SCL: spine cord length; ASA, American Society of Anesthesiologists.
